{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:15:01Z","timestamp":1789085701594,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59022-8","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:07:26Z","timestamp":1782029246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study"],"prefix":"10.1038","volume":"16","author":[{"given":"Elsebeth","family":"Staun-Ram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Neter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Glass-Marmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilli","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"59022_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2022.818652","volume":"13","author":"MF Wandall-Holm","year":"2022","unstructured":"Wandall-Holm, M. F., Andersen, M. A., Buron, M. D. & Magyari, M. Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks. Front. Neurol. 13, 1\u20139 (2022).","journal-title":"Front. Neurol."},{"key":"59022_CR2","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"FW Miller","year":"2023","unstructured":"Miller, F. W. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr. Opin. Immunol. 80, 102266 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"59022_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. J. 26, 1816\u20131821 (2020).","journal-title":"Mult Scler. J."},{"key":"59022_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","volume":"88","author":"HMB Lunde","year":"2017","unstructured":"Lunde, H. M. B., Assmus, J., Myhr, K. M., B\u00f8, L. & Grytten, N. Survival and cause of death in multiple sclerosis: A 60-year longitudinal population study. J. Neurol. Neurosurg. Psychiatry. 88, 621\u2013625 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"59022_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/1352458516671819","volume":"23","author":"K Ribbons","year":"2017","unstructured":"Ribbons, K., Lea, R., Tiedeman, C., Mackenzie, L. & Lechner-Scott, J. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study. Mult Scler. 23, 1063\u20131071 (2017).","journal-title":"Mult Scler."},{"key":"59022_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000493857","volume":"52","author":"F Grassivaro","year":"2019","unstructured":"Grassivaro, F. et al. Multiple sclerosis incidence and prevalence trends in the Province of Padua, Northeast Italy, 1965\u20132018. Neuroepidemiology 52, 41\u201346 (2019).","journal-title":"Neuroepidemiology"},{"key":"59022_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ane.12428","volume":"132","author":"N Grytten","year":"2015","unstructured":"Grytten, N., Myhr, K. M. & Torkildsen & Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol. Scand. 132, 29\u201336 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"59022_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen, N. & S\u00f8rensen, P. S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9, 520\u2013532 (2010).","journal-title":"Lancet Neurol."},{"key":"59022_CR9","unstructured":"MS International Federation. The Multiple Sclerosis International Federation Atlas of MS, 3rd edition. (2020). https:\/\/www.msif.org\/news\/atlas_toolkit\/atlas-3rd-edition-part-1-epidemiology-report-english-pdf\/ Available at: www.atlasofms.org"},{"key":"59022_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0b013e3181cf6ec0","volume":"74","author":"RA Marrie","year":"2010","unstructured":"Marrie, R. A., Blanchard, N. Y., Leung, S. & Elliot, L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 74, 465\u2013471 (2010).","journal-title":"Neurology"},{"key":"59022_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","volume":"15","author":"CB Vaughn","year":"2019","unstructured":"Vaughn, C. B. et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat. Reviews Neurol. 15, 329\u2013342 (2019).","journal-title":"Nat. Reviews Neurol."},{"key":"59022_CR12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1177\/1352458514561904","volume":"21","author":"C Solaro","year":"2015","unstructured":"Solaro, C. et al. The changing face of multiple sclerosis: Prevalence and incidence in an aging population. Mult Scler. 21, 1244\u20131250 (2015).","journal-title":"Mult Scler."},{"key":"59022_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1379538","volume":"15","author":"\u00d3 Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez, \u00d3. et al. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review. Front. Immunol. 15, 1\u201324 (2024).","journal-title":"Front. Immunol."},{"key":"59022_CR14","doi-asserted-by":"crossref","unstructured":"Capasso, N. et al. Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review. Front. Neurol. 14, 1207617 (2023).","DOI":"10.3389\/fneur.2023.1207617"},{"key":"59022_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves, J. S. et al. Ageing and multiple sclerosis. Lancet Neurol. 22, 66\u201377 (2023).","journal-title":"Lancet Neurol."},{"key":"59022_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.811518","volume":"12","author":"O Perdaens","year":"2022","unstructured":"Perdaens, O. & van Pesch, V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front. Neurol. 12, 1\u201329 (2022).","journal-title":"Front. Neurol."},{"key":"59022_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/13524585211007739","volume":"28","author":"M Cortese","year":"2022","unstructured":"Cortese, M., Bjornevik, K., Chitnis, T., Ascherio, A. & Munger, K. L. Aging with multiple sclerosis: A longitudinal study of physical function, mental health, and memory in two cohorts of US women. Mult Scler. J. 28, 121\u2013131 (2022).","journal-title":"Mult Scler. J."},{"key":"59022_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","volume":"80","author":"M Hittle","year":"2023","unstructured":"Hittle, M. et al. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. JAMA Neurol. 80, 693\u2013701 (2023).","journal-title":"JAMA Neurol."},{"key":"59022_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1212\/01.wnl.0000204194.47925.0d","volume":"66","author":"M Alter","year":"2006","unstructured":"Alter, M., Kahana, E., Zilber, N. & Miller, A. Multiple sclerosis frequency in Israel\u2019s diverse populations. Neurology 66, 1061\u20131066 (2006).","journal-title":"Neurology"},{"key":"59022_CR20","unstructured":"The Israeli National Insurence: Annual report on Israeli Health Maintenance Organizations. (2022). https:\/\/www.btl.gov.il\/Mediniyut\/Situation\/haveruth1\/2022\/Pages\/default.aspx"},{"key":"59022_CR21","unstructured":"The Central Bureau of Statistics: population according to ethnicity, religion, sex and age. (2022). https:\/\/www.cbs.gov.il\/en\/Surveys\/Pages\/Population-Census.aspx (2022)."},{"key":"59022_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/brain\/awae245","volume":"148","author":"RP Holm","year":"2025","unstructured":"Holm, R. P., Wandall-Holm, M. F. & Magyari, M. Multiple sclerosis in Denmark (1950\u20132023): mean age, sex distribution, incidence and prevalence. Brain 148, 626\u2013634 (2025).","journal-title":"Brain"},{"key":"59022_CR23","doi-asserted-by":"crossref","unstructured":"Amini, P., Almasi-Hashiani, A., Sahraian, M. A., Najafi, M. & Eskandarieh, S. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol. 21, 235 (2021).","DOI":"10.1186\/s12883-021-02281-x"},{"key":"59022_CR24","doi-asserted-by":"crossref","unstructured":"Abuawad, M. et al. Epidemiology of multiple sclerosis in West bank of Palestine. Mult Scler. Relat. Disord 59, 103686 (2022).","DOI":"10.1016\/j.msard.2022.103686"},{"key":"59022_CR25","doi-asserted-by":"crossref","unstructured":"Faraji, F., Ahmadi, F., Mohaghegh, P. & Talaie, A. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran. Mult Scler. Relat. Disord 60, 103691 (2022).","DOI":"10.1016\/j.msard.2022.103691"},{"key":"59022_CR26","doi-asserted-by":"publisher","first-page":"E1435","DOI":"10.1212\/WNL.0000000000005331","volume":"90","author":"DL Rotstein","year":"2018","unstructured":"Rotstein, D. L. et al. Temporal trends in multiple sclerosis prevalence and incidence in a large population. Neurology 90, E1435\u2013E1441 (2018).","journal-title":"Neurology"},{"key":"59022_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen, N. & Magyari, M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat. Reviews Neurol. 17, 676\u2013688 (2021).","journal-title":"Nat. Reviews Neurol."},{"key":"59022_CR28","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1007\/s00415-015-7842-0","volume":"262","author":"E Kingwell","year":"2015","unstructured":"Kingwell, E. et al. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991\u20132010). J. Neurol. 262, 2352\u20132363 (2015).","journal-title":"J. Neurol."},{"key":"59022_CR29","doi-asserted-by":"crossref","unstructured":"Abbastabar, H., Bitarafan, S., Mohammadpour, Z., Mohammadianinejad, S. E. & Harirchian, M. H. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran\u2019s corresponding values during 1990\u20132017: Retrieved from global burden of diseases data. Mult Scler. Relat. Disord 52, 102949 (2021).","DOI":"10.1016\/j.msard.2021.102949"},{"key":"59022_CR30","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1212\/WNL.0000000000213586","volume":"104","author":"O Guinebretiere","year":"2025","unstructured":"Guinebretiere, O. et al. Updated Multiple Sclerosis Incidence in France, 2011\u20132021. Neurology 104, 2011\u20132021 (2025).","journal-title":"Neurology"},{"key":"59022_CR31","doi-asserted-by":"publisher","first-page":"e1954","DOI":"10.1212\/WNL.0000000000005612","volume":"90","author":"N Koch-Henriksen","year":"2018","unstructured":"Koch-Henriksen, N., Thygesen, L. C., Stenager, E., Laursen, B. & Magyari, M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology 90, e1954\u2013e1963 (2018).","journal-title":"Neurology"},{"key":"59022_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jnnp-2022-329049","volume":"93","author":"L Prosperini","year":"2022","unstructured":"Prosperini, L. et al. Shift of multiple sclerosis onset towards older age. J. Neurol. Neurosurg. Psychiatry. 93, 1137\u20131139 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"59022_CR33","doi-asserted-by":"crossref","unstructured":"Romero-Pinel, L. et al. The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades. Mult Scler. Relat. Disord 68, 104103 (2022).","DOI":"10.1016\/j.msard.2022.104103"},{"key":"59022_CR34","doi-asserted-by":"crossref","unstructured":"Poser, C. M. & Brinar, V. V. Diagnostic criteria for multiple sclerosis: an historical review. Clin. Neurol. Neurosurg. 106, 147\u2013158 (2004).","DOI":"10.1016\/j.clineuro.2004.02.004"},{"key":"59022_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msard.2011.08.002","volume":"1","author":"A Gafson","year":"2012","unstructured":"Gafson, A., Giovannoni, G. & Hawkes, C. H. The diagnostic criteria for multiple sclerosis: From Charcot to McDonald. Mult Scler. Relat. Disord. 1, 9\u201314 (2012).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1379538","volume":"15","author":"\u00d3 Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez, \u00d3. et al. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review. Front. Immunol. 15, 1\u201324 (2024).","journal-title":"Front. Immunol."},{"key":"59022_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"C Poser","year":"1983","unstructured":"Poser, C. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227\u2013231 (1983).","journal-title":"Ann. Neurol."},{"key":"59022_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121\u2013127 (2001).","journal-title":"Ann. Neurol."},{"key":"59022_CR39","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u2018McDonald Criteria\u2019. Ann. Neurol. 58, 840\u2013846 (2005).","journal-title":"Ann. Neurol."},{"key":"59022_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011).","journal-title":"Ann. Neurol."},{"key":"59022_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"59022_CR42","first-page":"100","volume":"87","author":"N Grytten","year":"2016","unstructured":"Grytten, N., Aarseth, J. H., Lunde, H. M. B. & Myhr, K. M. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. J. Neurol. N. 87, 100\u2013105 (2016).","journal-title":"J. Neurol. N"},{"key":"59022_CR43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jnnp-2017-315907","volume":"88","author":"N Koch-Henriksen","year":"2017","unstructured":"Koch-Henriksen, N., Laursen, B., Stenager, E. & Magyari, M. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: A population based study. J. Neurol. Neurosurg. Psychiatry. 88, 626\u2013631 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"59022_CR44","doi-asserted-by":"crossref","unstructured":"Holm, R. P., Wandall-Holm, M. F., Sellebjerg, F. & Magyari, M. Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study. Front Neurol. 14, 1297709 (2023).","DOI":"10.3389\/fneur.2023.1297709"},{"key":"59022_CR45","doi-asserted-by":"publisher","first-page":"E1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin, M. T. et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology 92, E1029\u2013E1040 (2019).","journal-title":"Neurology"},{"key":"59022_CR46","doi-asserted-by":"publisher","first-page":"104845","DOI":"10.1016\/j.msard.2023.104845","volume":"77","author":"S Simpson-Yap","year":"2023","unstructured":"Simpson-Yap, S. et al. Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012\u20132022. Mult Scler. Relat. Disord. 77, 104845 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR47","doi-asserted-by":"crossref","unstructured":"Zeineddine, M., Hajje, A., Al, Hussein, A., El Ayoubi, N. & Yamout, B. Epidemiology of multiple sclerosis in Lebanon: a rising prevalence in the middle east. Mult Scler. Relat. Disord 52, 102963 (2021).","DOI":"10.1016\/j.msard.2021.102963"},{"key":"59022_CR48","first-page":"112","volume":"6","author":"A Abyad","year":"2021","unstructured":"Abyad, A. Ageing in the Middle-East and North Africa: Demographic and health trends. Int. J. Ageing Dev. Ctries. 6, 112\u2013128 (2021).","journal-title":"Int. J. Ageing Dev. Ctries."},{"key":"59022_CR49","doi-asserted-by":"publisher","first-page":"205521731989554","DOI":"10.1177\/2055217319895540","volume":"6","author":"SJ Khoury","year":"2020","unstructured":"Khoury, S. J. & Tintore, M. Multiple sclerosis in the Middle East and North Africa region. Multiple Scler. J. - Experimental Translational Clin. 6, 2055217319895540 (2020).","journal-title":"Multiple Scler. J. - Experimental Translational Clin."},{"key":"59022_CR50","first-page":"383","volume":"5","author":"F Azaiza","year":"2003","unstructured":"Azaiza, F. & Brodsky, J. The Aging of Israel\u2019s Arab Population: Needs, Existing Responses, and Dilemmas in the Development of Services for a Society in Transition. Isr. Med. Assoc. J. 5, 383\u2013386 (2003).","journal-title":"Isr. Med. Assoc. J."},{"key":"59022_CR51","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1177\/1352458512445059","volume":"12","author":"M Siegel","year":"2012","unstructured":"Siegel, M. et al. Multiple sclerosis in diverse populations: Characteristics in distinct Arab ethnicities in Israel. Mult Scler. J. 12, 1737\u20131744 (2012).","journal-title":"Mult Scler. J."},{"key":"59022_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/gene.2010.20","volume":"11","author":"G Benedek","year":"2010","unstructured":"Benedek, G. et al. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun. 11, 423\u2013431 (2010).","journal-title":"Genes Immun."},{"key":"59022_CR53","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.3390\/ijms241915024","volume":"24","author":"Z Nitzan","year":"2023","unstructured":"Nitzan, Z., Staun-Ram, E., Volkowich, A. & Miller, A. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet. Int. J. Mol. Sci. 24, 15024 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"59022_CR54","doi-asserted-by":"publisher","first-page":"123721","DOI":"10.1016\/j.jns.2025.123721","volume":"478","author":"R Spierer","year":"2025","unstructured":"Spierer, R., Hurani, M., Stein, N., Rawashdeh, A. & Bloch, S. Trends in prevalence and incidence of multiple sclerosis in the Israeli Jewish and Arab populations. J. Neurol. Sci. 478, 123721 (2025).","journal-title":"J. Neurol. Sci."},{"key":"59022_CR55","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"GBD 2021 Rheumatoid Arthritis Collaborators","year":"2023","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 5, e594\u2013610 (2023).","journal-title":"Lancet Rheumatol."},{"key":"59022_CR56","doi-asserted-by":"publisher","first-page":"102036","DOI":"10.1016\/j.berh.2025.102036","volume":"39","author":"P Uke","year":"2025","unstructured":"Uke, P., Maharaj, A. & Adebajo, A. A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature. Best Pract. Res. Clin. Rheumatol. 39, 102036 (2025).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"59022_CR57","first-page":"1291","volume":"12","author":"Y Cai","year":"2023","unstructured":"Cai, Y. et al. The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis. J. Clin. Invest. 12, 1291 (2023).","journal-title":"J. Clin. Invest."},{"key":"59022_CR58","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","volume":"79","author":"E Myasoedova","year":"2020","unstructured":"Myasoedova, E., Davis, I. I. I., Matteson, J., Crowson, C. & E. & Is The Epidemiology Of Rheumatoid Arthritis Changing? Results From a Population-based Incidence Study, 1985\u20132014. Ann. Rheum. Dis. 79, 440\u2013444 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"59022_CR59","doi-asserted-by":"crossref","unstructured":"Mousavi, S. E. et al. The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990\u20132019. Sci. Rep. 12, 19297 (2022).","DOI":"10.1038\/s41598-022-22310-0"},{"key":"59022_CR60","first-page":"1","volume":"17","author":"C Oreja-Guevara","year":"2024","unstructured":"Oreja-Guevara, C. et al. Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management. Ther. Adv. Neurol. Disord Disord. 17, 1\u201310 (2024).","journal-title":"Ther. Adv. Neurol. Disord Disord"},{"key":"59022_CR61","doi-asserted-by":"crossref","unstructured":"Casanova, B., Quintanilla-Bord\u00e1s, C. & Gasc\u00f3n, F. Escalation vs. early intense therapy in multiple sclerosis. J. Pers. Med. 12, 119 (2022).","DOI":"10.3390\/jpm12010119"},{"key":"59022_CR62","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/brain\/awz055","volume":"142","author":"E Kingwell","year":"2019","unstructured":"Kingwell, E. et al. Multiple sclerosis: Effect of beta interferon treatment on survival. Brain 142, 1324\u20131333 (2019).","journal-title":"Brain"},{"key":"59022_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ene.14040","volume":"27","author":"I Chou","year":"2020","unstructured":"Chou, I. et al. Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality. Eur. J. Neurol. 27, 105\u2013112 (2020).","journal-title":"Eur. J. Neurol."},{"key":"59022_CR64","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","volume":"4","author":"G Capkun","year":"2015","unstructured":"Capkun, G. et al. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Mult Scler. Relat. Disord. 4, 546\u2013554 (2015).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie, R. A. et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview. Mult Scler. J. 21, 263\u2013281 (2015).","journal-title":"Mult Scler. J."},{"key":"59022_CR66","doi-asserted-by":"publisher","first-page":"e70176","DOI":"10.1111\/ene.70176","volume":"32","author":"A Zinganell","year":"2025","unstructured":"Zinganell, A. et al. Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature Review. Eur. J. Neurol. J. Neurol. 32, e70176 (2025).","journal-title":"Eur. J. Neurol. J. Neurol."},{"key":"59022_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2009.09.012","volume":"287","author":"C Sioka","year":"2009","unstructured":"Sioka, C., Kyritsis, A. P. & Fotopoulos, A. Journal of the Neurological Sciences Multiple sclerosis, osteoporosis, and vitamin D. J. Neurol. Sci. 287, 1\u20136 (2009).","journal-title":"J. Neurol. Sci."},{"key":"59022_CR68","doi-asserted-by":"publisher","first-page":"102815","DOI":"10.1016\/j.msard.2021.102815","volume":"50","author":"A Ostolaza","year":"2021","unstructured":"Ostolaza, A., Corroza, J. & Ayuso, T. Multiple sclerosis and aging: comorbidity and treatment challenges. Mult Scler. Relat. Disord. 50, 102815 (2021).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR69","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000128103","volume":"30","author":"N Allen","year":"2008","unstructured":"Allen, N. et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidimiology 30, 234\u2013238 (2008).","journal-title":"Neuroepidimiology"},{"key":"59022_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000320245","volume":"35","author":"C Christensen","year":"2010","unstructured":"Christensen, C. et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology 35, 267\u2013274 (2010).","journal-title":"Neuroepidemiology"},{"key":"59022_CR71","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2105\/AJPH.2016.303326","volume":"106","author":"A Hruby","year":"2016","unstructured":"Hruby, A. et al. Determinants and Consequences of Obesity. Am. J. Public. Heal. 106, 1656\u20131662 (2016).","journal-title":"Am. J. Public. Heal"},{"key":"59022_CR72","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/1352458512437814","volume":"18","author":"RA Marrie","year":"2012","unstructured":"Marrie, R. A. et al. Rising prevalence of vascular comorbidities in multiple sclerosis: Validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler. J. 18, 1310\u20131319 (2012).","journal-title":"Mult Scler. J."},{"key":"59022_CR73","doi-asserted-by":"publisher","first-page":"104693","DOI":"10.1016\/j.msard.2023.104693","volume":"74","author":"Z Amiri","year":"2023","unstructured":"Amiri, Z. et al. Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran. Mult Scler. Relat. Disord. 74, 104693 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR74","doi-asserted-by":"publisher","first-page":"e209885","DOI":"10.1212\/WNL.0000000000209885","volume":"103","author":"C Pierret","year":"2024","unstructured":"Pierret, C. et al. Cancer Risk Among Patients With Multiple Sclerosis. Neurology 103, e209885 (2024).","journal-title":"Neurology"},{"key":"59022_CR75","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/ene.15226","volume":"29","author":"P Bosco- L\u00e9vy","year":"2022","unstructured":"Bosco- L\u00e9vy, P. et al. Incidence and risk of cancer among multiple sclerosis patients: A matched population- based cohort study. Eur. J. Neurol. 29, 1091\u20131099 (2022).","journal-title":"Eur. J. Neurol."},{"key":"59022_CR76","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1177\/1352458519877244","volume":"26","author":"N Grytten","year":"2020","unstructured":"Grytten, N. et al. Risk of cancer among multiple sclerosis patients, siblings, and population controls : A prospective cohort study. Mult Scler. J. 26, 1569\u20131580 (2020).","journal-title":"Mult Scler. J."},{"key":"59022_CR77","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1352458514564489","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie, R. A. et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler. J. 21, 294\u2013304 (2015).","journal-title":"Mult Scler. J."},{"key":"59022_CR78","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1177\/13524585231204122","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Atkinson, J., Burd, C. E., Graves, J. & Segal, B. M. Biological aging in multiple sclerosis. Multiple Scler. J. 29, 1701\u20131708 (2023).","journal-title":"Multiple Scler. J."},{"key":"59022_CR79","doi-asserted-by":"publisher","first-page":"1197195","DOI":"10.3389\/fimmu.2023.1197195","volume":"14","author":"RA Marrie","year":"2023","unstructured":"Marrie, R. A. et al. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances. Front. Immunol. 14, 1197195 (2023).","journal-title":"Front. Immunol."},{"key":"59022_CR80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/13524585221074010","volume":"28","author":"M Moccia","year":"2022","unstructured":"Moccia, M. et al. Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy). Mult Scler. J. 28, 597\u2013607 (2022).","journal-title":"Mult Scler. J."},{"key":"59022_CR81","doi-asserted-by":"publisher","first-page":"101955","DOI":"10.1016\/j.msard.2020.101955","volume":"40","author":"L Al-Sakran","year":"2020","unstructured":"Al-Sakran, L., Marrie, R. A., Blackburn, D., Knox, K. & Evans, C. Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study. Mult Scler. Relat. Disord. 40, 101955 (2020).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7224\/1537-2073.2019-030","volume":"22","author":"H Al Dandan","year":"2020","unstructured":"Al Dandan, H., Coote, S. & McClurg, D. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis A Systematic Review and Meta-analysis. Int. J. MS Care. 22, 91\u201399 (2020).","journal-title":"Int. J. MS Care"},{"key":"59022_CR83","doi-asserted-by":"publisher","first-page":"101982","DOI":"10.1016\/j.msard.2020.101982","volume":"41","author":"R Persson","year":"2020","unstructured":"Persson, R. et al. Infections in patients diagnosed with multiple sclerosis: A multi-database study. Mult Scler. Relat. Disord. 41, 101982 (2020).","journal-title":"Mult Scler. Relat. Disord"},{"key":"59022_CR84","doi-asserted-by":"publisher","first-page":"e200164","DOI":"10.1212\/NXI.0000000000200164","volume":"10","author":"AM Langer-gould","year":"2023","unstructured":"Langer-gould, A. M., Smith, J. B., Gonzales, E. G. & Piehl, F. Multiple Sclerosis, Disease-Modifying Therapies, and Infections. Neurol. Neuroimmunol. Neuroinflamm. 10, e200164 (2023).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"59022_CR85","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejrad.2009.04.050","volume":"71","author":"K Trieb","year":"2009","unstructured":"Trieb, K. & Hofstaetter, S. Treatment strategies in surgery for rheumatoid arthritis. Eur. J. Radiol. 71, 204\u2013210 (2009).","journal-title":"Eur. J. Radiol."},{"key":"59022_CR86","doi-asserted-by":"publisher","first-page":"1197212","DOI":"10.3389\/fneur.2023.1197212","volume":"14","author":"G Macaron","year":"2023","unstructured":"Macaron, G. et al. Impact of aging on treatment considerations for multiple sclerosis patients. Front. Neurol. 14, 1197212 (2023).","journal-title":"Front. Neurol."},{"key":"59022_CR87","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00018-023-04832-6","volume":"80","author":"F Gaspar-Silva","year":"2023","unstructured":"Gaspar-Silva, F., Trigo, D. & Magalhaes, J. Ageing in the brain: mechanisms and rejuvenating strategies. Cell. Mol. Life Sci. 80, 190 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"59022_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1196\/annals.1361.066","volume":"1051","author":"M Thewissen","year":"2005","unstructured":"Thewissen, M. et al. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann. N Y Acad. Sci. 1051, 255\u2013262 (2005).","journal-title":"Ann. N Y Acad. Sci."},{"key":"59022_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12979-020-00178-w","volume":"17","author":"M Bauer","year":"2020","unstructured":"Bauer, M. Accelerated immunosenescence in rheumatoid arthritis impact on clinical progression. Immun. Ageing. 17, 6 (2020).","journal-title":"Immun. Ageing"},{"key":"59022_CR90","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fneur.2017.00577","volume":"8","author":"AM Weideman","year":"2017","unstructured":"Weideman, A. M., Tapia-Maltos, M. A., Johnson, K., Greenwood, M. & Bielekova, B. Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments. Front. Neurol. 8, 577 (2017).","journal-title":"Front. Neurol."},{"key":"59022_CR91","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1177\/1352458520964778","volume":"27","author":"L Prosperini","year":"2021","unstructured":"Prosperini, L., Haggiag, S., Tortorella, C., Galgani, S. & Gasperini, C. Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression. Mult Scler. J. 27, 1391\u20131402 (2021).","journal-title":"Mult Scler. J."},{"key":"59022_CR92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14737175.2021.1886082","volume":"21","author":"D Jakimovski","year":"2021","unstructured":"Jakimovski, D., Eckert, S. P., Zivadinov, R. & Weinstock-Guttman, B. Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Rev. Neurother. 21, 353\u2013364 (2021).","journal-title":"Expert Rev. Neurother."},{"key":"59022_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20406223221108391","volume":"13","author":"J Debus","year":"2022","unstructured":"Debus, J., Bachmann, P., Frahm, N., Mashhadiakbar, P. & Langhorst, S. Associated factors of potential drug-drug interactions and drug\u2013food interactions in patients with multiple sclerosis. Ther. Adv. Chronic Dis. 13, 1\u201319 (2022).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"59022_CR94","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/ene.13745","volume":"25","author":"E D\u2019Amico","year":"2018","unstructured":"D\u2019Amico, E. et al. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study. Eur. J. Neurol. 25, 1425\u20131431 (2018).","journal-title":"Eur. J. Neurol."},{"key":"59022_CR95","doi-asserted-by":"crossref","unstructured":"Hurani, M., Lavi, I., Bloch, S. & Golan, D. The prevalence of multiple sclerosis in Israel based on validation of a health care organization database. Sci Rep 14, 25070 (2024).","DOI":"10.1038\/s41598-024-76282-4"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59022-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:05:17Z","timestamp":1789085117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59022"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59022-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28384"}}